sure is quiet as far as my shares are concerned. having said that, LUMACOM have starred, and continue to march northwards... a shame that i do not have too many of them. a highly speculative play, and not worth putting too much into
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
